Form 10-Q NovaBay Pharmaceuticals, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Six dead in 'stampede-like' incident at India temple, ANI says
NovaBay Pharma (NBY) Misses Q2 EPS by 6c
August 11, 2016 5:09 PM EDTNovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $1.76 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More